Familial Hodgkin's and non-Hodgkin's lymphoma: Different patterns in first-degree relatives

被引:10
|
作者
Siebert, R [1 ]
Louie, D [1 ]
Lacher, M [1 ]
Schluger, A [1 ]
Offit, K [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Human Genet, Clin Genet Serv, New York, NY 10021 USA
关键词
Hodgkin's disease; non-Hodgkin's lymphoma; genetics; familial; first-degree relatives;
D O I
10.3109/10428199709058317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to evaluate the importance of genetic susceptibility in Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) we retrospectively analysed 31 families with lymphoma in first-degree relatives containing a total of 65 affected persons. We observed 20 HD/HD, 8 NHL/HD and 8 NHL/NHL pairs with median ages of diagnosis of 27, 36 and 48 years, respectively (p < 0.001). In HD/HD sib pairs were predominant in contrast to parent/child pairs in NHL/NHL (p = 0.04). There was a higher frequency of diseases with impaired immune function in NHL/NHL than in other pairs (p = 0.01). Comparison of ages and times of incidence of the pairs as well as sex-concordance rates are consistent with an age-specific genetic susceptibility to HD, but suggest a time-specific exposure in some NHL-prone families with or without compromised immune function.
引用
收藏
页码:503 / 507
页数:5
相关论文
共 50 条
  • [41] Checkpoint Inhibition in Non-Hodgkin's Lymphoma
    Hess, Georg
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11) : 662 - 672
  • [42] BRAF mutations in non-Hodgkin's lymphoma
    Lee, JW
    Yoo, NJ
    Soung, YH
    Kim, HS
    Park, WS
    Kim, SY
    Lee, JH
    Park, JY
    Cho, YG
    Kim, CJ
    Ko, YH
    Kim, SH
    Nam, SW
    Lee, JY
    Lee, SH
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1958 - 1960
  • [43] Non-Hodgkin's lymphoma of the sinonasal tract
    Quraishi, MS
    Bessell, EM
    Clark, D
    Jones, NS
    Bradley, PJ
    LARYNGOSCOPE, 2000, 110 (09) : 1489 - 1492
  • [44] Epidemiology of Non-Hodgkin's Lymphoma in India
    Nair, Reena
    Arora, Neeraj
    Mallath, Mohandas K.
    ONCOLOGY, 2016, 91 : 18 - 25
  • [45] The allogeneic effect in non-Hodgkin's lymphoma
    Goldstone, AH
    Kottaridis, PD
    LEUKEMIA & LYMPHOMA, 2003, 44 : S91 - S97
  • [46] Palliative chemotherapy in non-Hodgkin's lymphoma
    Salminen, E
    Nikkanen, V
    Lindholm, L
    ONCOLOGY, 1997, 54 (02) : 108 - 111
  • [47] Primary pulmonary non-Hodgkin's lymphoma
    Kim, JH
    Lee, SH
    Park, J
    Kim, HY
    Lee, SI
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    Han, JH
    Ko, YH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) : 510 - 514
  • [48] Rituximab in the treatment of non-Hodgkin's lymphoma
    Hauptrock, Beate
    Hess, Georg
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04) : 619 - 633
  • [49] Radiotherapy for Hodgkin's and non-Hodgkin's lymphoma. Indications, techniques, and results
    EngenhartCabillic, R
    Debus, J
    Wannenmacher, M
    RADIOLOGE, 1997, 37 (01): : 81 - 88
  • [50] The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment
    Enrici, RM
    Anselmo, AP
    Iacari, V
    Osti, MF
    Santoro, M
    Tombolini, V
    Mandelli, F
    Biagini, C
    HAEMATOLOGICA, 1998, 83 (07) : 636 - 644